The satellite will provide insights into the acceptability of various prevention products among specific vulnerable population groups across East Africa and India. It will also highlight the need to bring together different stakeholders, in addition to the end-users, early on at the time of clinical development planning. The essence of technological advancements and health system delivery lessons in the post-COVID era, which may serve as useful leads for future product planning, will be discussed, which will help guide product developers in defining the unique value proposition for upcoming prevention interventions, account for specific importance to critical product attributes and identify effective communication channels and delivery strategies. It will also help funders to direct investments in areas where they are needed. Most importantly, the session will re-emphasize the need to have community voices and user choices at the heart of product development.